Composition of Certain Financial Statement Captions (Tables)

3 Months Ended

Mar. 31, 2015



(In thousands)	March 31, 2015			December 31, 2014
Accounts receivable, net
Accounts receivable	$	20,755		$	21,875
Less: allowance for doubtful accounts	(1,691		)	(1,906		)
	$	19,064		$	19,969
Inventories, net
Finished products	$	14,349		$	12,116
Work in-process	891			1,011
Raw materials	3,638			4,116
Less: inventory reserve	(554		)	(639		)
	$	18,324		$	16,604
Prepaid expenses and other current assets
Prepaid supplies	$	1,319		$	1,123
Prepaid insurance	1,041			968
Other receivables	733			669
Taxes recoverable	1,968			2,417
Other	3,384			4,212
	$	8,445		$	9,389
Intangible assets, net:
Technologies	$	52,167		$	52,508
Customer relationships	21,943			22,108
Product registrations	8,224			8,763
Trade names	3,417			3,483
Covenants not to compete	8,618			8,639
Other	991			1,079
Less: accumulated amortization	(35,928		)	(33,931		)
	$	59,432		$	62,649
Accrued expenses:
Taxes payable	$	3,008		$	77
Deferred revenue	74,789			4,185
Clinical trials	9,620			8,643
Professional fees	1,624			1,860
Employee benefits	6,495			4,127
Contingent consideration	52,838			27,352
Other	10,389			14,668
	$	158,763		$	60,912



(In thousands)	March 31, 2015		December 31, 2014
Other long-term liabilities:
Contingent consideration – OPKO Renal	$	18,841	$	36,529
Contingent consideration – OPKO Health Europe	—		254
Contingent consideration – OPKO Diagnostics	4,375		6,992
Contingent consideration – CURNA	457		440
Mortgages and other debts payable	2,185		2,434
Deferred tax liabilities	166,922		167,153
Deferred revenue	214,017		2,526
Other	3,368		1,030
	$	410,165	$	217,358

The following table reflects the changes in Goodwill during the three months ended March 31, 2015.